Foldax® Announces Positive 1-Year Data on TRIA™ Mitral Valve
Disclaimer

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.

Limited by Federal (or United States) law to investigational use only.
Continue To Site

You are switching to a website for another country and will be subject to the terms and policies therein. Products on that website may or may not be available or approved for your location. Please contact your Foldax representative if you have questions about the availability of products in your location. By continuing, you acknowledge and agree to the terms of this notice.

Go Back
Continue
Home
Our Technology
Clinical Evidence
For Patients
About
News
Partnerships
Contact
Our Technology
Clinical Evidence
Patients
About
News
Partnerships
US
IN
Contact Us

A Game Changer in Heart Valve Innovation

Combining advanced materials and cutting-edge automation to create a new standard in heart valve technology.
Contact Us

Limited by Federal (or United States) law to investigational use only.
TRIA™ Mitral Valves are approved for use in India by CDSCO

ANNOUNCEMENT

Foldax® Announces Positive 1-Year Data on TRIA™ Mitral Valve

View Publication
View Press Release

Where Novel LifePolymer™ Meets Robotic Manufacturing

Developed for Durability

Uniquely formulated polymer developed specifically for heart valves, “LifePolymer™” material is biocompatible, resists calcification, and eliminates the need for animal-based sourcing.1,2

Manufactured with Precision

Robotic automation ensures precision and consistency, reducing manufacturing costs and enabling scalable production to meet growing demand.3

Designed for Patient Access

TRIA™ valves are designed to meet the needs of diverse patient groups, including younger individuals and those with conditions like rheumatic heart disease (RHD), enabling broader demographic access.

TRIA™ Valves: A Revolution in Heart Valve Technology

Discover the Future of Heart Valve Technology with Foldax®

Explore our groundbreaking innovations through these videos, showcasing how we are addressing global unmet needs and transforming heart valve technology.

Future of Heart Valves
Robotic Manufacturing
Foldax® Animation

Learn How Foldax® is Transforming Heart Valve Therapy

Press Releases
Publications
Presentations

Real Lives and Real Stories Show the Impact of Foldax’s® Valves

Bob, the first patient to receive a TRIA™ heart valve, celebrates his five year anniversary! Hear how Bob’s life has changed since he received the TRIA™ valve.

Watch Video

Joe talks about why he chose the TRIA™ heart valve and how it has helped him get back to doing the things he loves.

Watch Video
Our TechnologyClinical EvidencePatientsAboutNewsPartnershipsContact
Foldax® is reinventing every aspect of the heart valve – from material to design to manufacturing – to develop surgical and transcatheter valves designed to last a lifetime addressing historical tradeoffs between tissue and mechanical valves.

For more information on current clinical investigations, please go to: ClincialTrials.gov

TRIA™ Heart Valves are Investigational devices. Limited by Federal (or United States) law to investigational use. TRIA™ Mitral Valves are approved for use in India by CDSCO

Information contained on this website is for reference only.
Clinical References
Privacy Policy
Terms of Use
LA-0096 Rev. B